SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 Lyell Immunopharma, Inc. , a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid.
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.